ALEXANDRIA, Va., June 17 -- United States Patent no. 12,311,019, issued on May 27, was assigned to Imugene Ltd. (Carlton, Australia).
"Vaccine composition and uses thereof" was invented by Nicholas Ede (Victoria, Australia), Ursula Wiedermann (Vienna), Joshua Tobias (Vienna) and Christoph Zielinski (Vienna).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a vaccine composition for raising a humoral response to PD1, and uses thereof, for treating a cancer characterised by an involvement of PD1, wherein the vaccine composition comprises an effective amount of an immunogen that induces an antibody response in which the antibody binds to a B cell epitope of PD1."
The patent was filed on Feb. 7,...